Endoglin: Beyond the Endothelium

por Schoonderwoerd, Mark J. A., Goumans, Marie-Jose T. H., Hawinkels, Lukas J. A. C.
Publicado 2020

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

por Kleinovink, Jan Willem, Marijt, Koen A., Schoonderwoerd, Mark J. A., van Hall, Thorbald, Ossendorp, Ferry, Fransen, Marieke F.
Publicado 2017

Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model

por Schoonderwoerd, Mark J A, Hakuno, Sarah K, Sassen, Martijn, Kuhlemaijer, Eleonore B, Paauwe, Madelon, Slingerland, Marije, Fransen, Marieke F, Hawinkels, Lukas J A C
Publicado 2021

Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus

por Harryvan, Tom J., Golo, Matteo, Dam, Nicole, Schoonderwoerd, Mark J. A., Farshadi, Elham Aida, Hornsveld, Marten, Hoeben, Rob C., Hawinkels, Lukas J. A. C., Kemp, Vera
Publicado 2022

Mesenchymal stromal cells prevent progression of liver fibrosis in a novel zebrafish embryo model

por van der Helm, Danny, Groenewoud, Arwin, de Jonge-Muller, Eveline S. M., Barnhoorn, Marieke. C., Schoonderwoerd, Mark J. A., Coenraad, Minneke J., Hawinkels, Lukas J. A. C., Snaar-Jagalska, B. Ewa, van Hoek, Bart, Verspaget, Hein W.
Publicado 2018

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

por Kumar, Sumit, Schoonderwoerd, Mark J A, Kroonen, Jessie S, de Graaf, Ilona J, Sluijter, Marjolein, Ruano, Dina, González-Prieto, Román, Verlaan-de Vries, Matty, Rip, Jasper, Arens, Ramon, de Miranda, Noel F C C, Hawinkels, Lukas J A C, van Hall, Thorbald, Vertegaal, Alfred C O
Publicado 2022